|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.365 GBX | -1.35% |
|
+8.96% | -41.60% |
| Apr. 11 | Oxford Cannabinoid teams with iNGENu to test OCT130401 pain treatment | AN |
| Apr. 09 | Oxford Cannabinoid Technologies Holdings plc Appoints Timothy Henry Corn as A Director | CI |
Oxford Cannabinoid Technologies Holdings Plc reported earnings results for the half year ended October 31, 2023. For the half year, the company reported net loss was GBP 2 million compared to GBP 3.71 million a year ago. Basic loss per share from continuing operations was GBP 0.00208 compared to GBP 0.00386 a year ago.
Diluted loss per share from continuing operations was GBP 0.00208 compared to GBP 0.00386 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -41.60% | 4.95M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC 
